Abstract
Epstein-Barr virus (EBV) is a common herpesvirus that may cause asymptomatic infection or various diseases, such as mononucleosis, lymphoproliferative disorders and several cancers. Our objective was to estimate the prevalence of EBV among patients hospitalized in “Luigi Vanvitelli” University Hospital in the last 10 years. Our results showed that EBV seroprevalence in our geographical area was 65%. Seroprevalence increased gradually with age with no significant difference between females (49.42%) and males (50.58%). The seropositivity for primary infection was higher in patients about 5 years old, while seropositivity for past infection was predominant in patients of about 35 years old. These results underline that children in our country are still exposed to EBV. The development and the deeper use of an EBV vaccine in the early years of life could represent the solution for this infection.
References
1.
Evans
AS
. Infectious mononucleosis and related syndromes
. Am J Med Sci
. 1978
Nov-Dec
;276
(3
):325
–39
.
[PubMed]
0002-96292.
Pender
MP
. CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis
. Autoimmune Dis
. 2012
;2012
:189096
.
[PubMed]
2090-04303.
Ascherio
A
, Munger
KL
. Epstein-barr virus infection and multiple sclerosis: a review
. J Neuroimmune Pharmacol
. 2010
Sep
;5
(3
):271
–7
.
[PubMed]
1557-19044.
Amon
W
, Farrell
PJ
. Reactivation of Epstein-Barr virus from latency
. Rev Med Virol
. 2005
May-Jun
;15
(3
):149
–56
.
[PubMed]
1052-92765.
Jha
HC
, Pei
Y
, Robertson
ES
. Epstein-Barr Virus: Diseases Linked to Infection and Transformation
. Front Microbiol
. 2016
Oct
;7
:1602
.
[PubMed]
1664-302X6.
Sprunt
TP
. Chronic Lymph Node Enlargement with Mononucleosis
. Trans Am Climatol Clin Assoc
. 1931
;47
:248
–52
.
[PubMed]
0743-32557.
Odumade
OA
, Hogquist
KA
, Balfour
HH
Jr. Progress and problems in understanding and managing primary Epstein-Barr virus infections
. Clin Microbiol Rev
. 2011
Jan
;24
(1
):193
–209
.
[PubMed]
1098-66188.
Sidagis
J
, Ueno
K
, Tokunaga
M
, Ohyama
M
, Eizuru
Y
. Molecular epidemiology of Epstein-Barr virus (EBV) in EBV-related malignancies
. Int J Cancer
. 1997
Jul
;72
(1
):72
–6
.
[PubMed]
0020-71369.
Xiong
G
, Zhang
B
, Huang
MY
, Zhou
H
, Chen
LZ
, Feng
QS
, et al. Epstein-Barr virus (EBV) infection in Chinese children: a retrospective study of age-specific prevalence
. PLoS One
. 2014
Jun
;9
(6
):e99857
.
[PubMed]
1932-620310.
Fourcade
G
, Germi
R
, Guerber
F
, Lupo
J
, Baccard
M
, Seigneurin
A
, et al. Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000-2016
. PLoS One
. 2017
Apr
;12
(4
):e0175574
.
[PubMed]
1932-620311.
Takeuchi
K
, Tanaka-Taya
K
, Kazuyama
Y
, Ito
YM
, Hashimoto
S
, Fukayama
M
, et al. Prevalence of Epstein-Barr virus in Japan: trends and future prediction
. Pathol Int
. 2006
Mar
;56
(3
):112
–6
.
[PubMed]
1320-546312.
Balfour
HH
Jr, Sifakis
F
, Sliman
JA
, Knight
JA
, Schmeling
DO
, Thomas
W
. Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition
. J Infect Dis
. 2013
Oct
;208
(8
):1286
–93
.
[PubMed]
1537-661313.
Morris
MC
, Edmunds
WJ
, Hesketh
LM
, Vyse
AJ
, Miller
E
, Morgan-Capner
P
, et al. Sero-epidemiological patterns of Epstein-Barr and herpes simplex (HSV-1 and HSV-2) viruses in England and Wales
. J Med Virol
. 2002
Aug
;67
(4
):522
–7
.
[PubMed]
0146-661514.
Suntornlohanakul
R
, Wanlapakorn
N
, Vongpunsawad
S
, Thongmee
T
, Chansaenroj
J
, Poovorawan
Y
. Seroprevalence of Anti-EBV IgG among Various Age Groups from Khon Kaen Province, Thailand
. Asian Pac J Cancer Prev
. 2015
;16
(17
):7583
–7
.
[PubMed]
2476-762X15.
Chen
CY
, Huang
KY
, Shen
JH
, Tsao
KC
, Huang
YC
. A large-scale seroprevalence of Epstein-Barr virus in Taiwan
. PLoS One
. 2015
Jan
;10
(1
):e0115836
.
[PubMed]
1932-620316.
Balfour
HH
Jr, Odumade
OA
, Schmeling
DO
, Mullan
BD
, Ed
JA
, Knight
JA
, et al. Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students
. J Infect Dis
. 2013
Jan
;207
(1
):80
–8
.
[PubMed]
1537-661317.
Ferrés
M
, Prado
P
, Ovalle
J
, Fuentes
R
, Villarroel
L
, Ferreccio
C
, et al. [Seroprevalence of Epstein Barr virus infection in a healthy population of Santiago de Chile]
. Rev Med Chil
. 1995
Dec
;123
(12
):1447
–52
.
[PubMed]
0034-988718.
Condon
LM
, Cederberg
LE
, Rabinovitch
MD
, Liebo
RV
, Go
JC
, Delaney
AS
, et al. Age-specific prevalence of Epstein-Barr virus infection among Minnesota children: effects of race/ethnicity and family environment
. Clin Infect Dis
. 2014
Aug
;59
(4
):501
–8
.
[PubMed]
1537-659119.
Leogrande
G
, Jirillo
E
. Studies on the epidemiology of child infections in the Bari area (south Italy). VII. Epidemiology of Epstein-Barr virus infections
. Eur J Epidemiol
. 1993
Jul
;9
(4
):368
–72
.
[PubMed]
0393-2990© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
